UBC Rapid test is manufactured by a Swedish company IDL Biotech, which develops, produces and sells tests for in vitro diagnostics (IVD) around the world. 

UBC RAPID

UBC Rapid is a non-invasive cassette test designed for the rapid diagnosis and monitoring of bladder cancer.

The sample is the patient’s urine, in which the level of cytokeratins 8 and 18 is measured. A qualitative result is obtained within 10 minutes. 

Thanks to the use of the Concile 100 Ω Reader offered together with UBC Rapid test, we can obtain a quantitative result that can be used in the morning of early symptoms of bladder cancer, as well as in the monitoring of treatment of bladder cancer.

 

 

UBC Rapid

·       Insensitive  to urine contamination with blood

·       High diagnostic sensitivity of 68% (high grade; CIS, T1G2,

T1G3, T2-T4)

·       Proven efficacy in routine use in Germany